ArticleJournal of animal physiology and animal nutrition2026
Extrusion and Pancreatin Superdosing Modulate the Metabolic Impact of 20% Chlorella vulgaris Inclusion in Broiler Diets.
Article in Journal of animal physiology and animal nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extrusion and Pancreatin Superdosing Modulate the Metabolic Impact of 20% Chlorella vulgaris Inclusion in Broiler Diets.Journal of animal physiology and animal nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Microalgae such as Chlorella vulgaris are gaining attention as sustainable and nutritionally valuable feed ingredients, with the potential to partially replace soybean meal in broiler diets. However, dietary inclusion of 20% C. vulgaris has been attempted, but negatively affected growth performance due to limited digestibility. This study examined the effects of including 20% Chlorella vulgaris (C. vulgaris) in broiler diets, either alone, extruded, or combined with 0.3% pancreatin supplementation, on blood parameters, plasma biochemistry, and liver composition. From day 7 to 35 of age, four dietary treatments were applied: a standard control diet (CTR), a diet with 20% C. vulgaris (CV), a diet with 20% C. vulgaris supplemented with 0.3% pancreatin (CVEN), and a diet containing 20% extruded C. vulgaris (CVEX). Findings showed that C. vulgaris dietary incorporation, regardless of treatment, led to a significant reduction in growth performance and an increase in specific plasma lipid parameters (p < 0.05) when compared with the CTR diet. However, in CVEN animals, such adverse effects were mitigated, resulting in improvements in final body weight and average body weight gain. Dietary inclusion of C. vulgaris modulated hepatic composition without affecting total hepatic lipid content. Chlorella-based diets lowered PUFA/SFA and n-6/n-3 ratios and increased specific fatty acids, particularly C16:0 and 20:5n-3. Hepatic cholesterol and antioxidant-related compounds, including β-carotene, chlorophyll a-like pigments, α-tocopherol, and, in untreated C. vulgaris, γ-tocopherol and γ-tocotrienol, were increased, and multivariate analysis clearly separated CTR diet-fed birds from Chlorella-fed groups. Multivariate analysis identified treatment-related patterns in both blood and liver samples. PCA of plasma parameters clearly separated all dietary groups. Conversely, hepatic PCA distinguished control from C. vulgaris treatments, which clustered together regardless of processing or enzyme supplementation, indicating consistent liver responses to microalgae dietary inclusion. Overall, these findings indicate that a 20% inclusion level of C. vulgaris requires digestibility-enhancing strategies to sustain broiler growth performance. Pancreatin supplementation effectively restored performance at this inclusion level to levels comparable to those of conventional maize-soy diets, highlighting the potential of enzyme-treated C. vulgaris as a viable main ingredient that supports both production outcomes and health-related attributes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.